Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Dynavax to Lay Off 37 Percent of Staff, CEO to Retire

Dynavax CEO Eddie Gray will step down from his role on Aug. 1, 2019, as the Bay Area company undergoes restructuring to move away from immuno-oncology and prioritize the vaccine business.

Read More »

Novartis Poaches GSK Veteran as New Sandoz CEO

GlaxoSmithKline veteran Richard Saynor is coming home to Sandoz after being named the new chief executive officer of the Novartis subsidiary.

Read More »

A Promotion and a Departure at FCB Health

One is going, one is staying – and getting a promotion.

Read More »

Novartis generics boss quits amid conjecture over business’s future

Novartis’ generics chief stepped down after the Swiss drugmaker sold parts of the business and initiated an 18-month revamp, fueling speculation about an eventual spin-off or sale.

Read More »

U.S. FDA chief steps down abruptly

FDA Commissioner Scott Gottlieb plans to step down in April 2019, a sudden resignation that calls into question how the regulatory agency will handle issues such as surging e-cigarette use among teens and efforts to increase competition in prescription drugs.

Read More »

BioSpace Movers and Shakers: March 1, 2019

Chief Commercial Officer Steven Hoerter resigned his role at Agios Pharmaceuticals to accept a role as chief executive officer at an oncology-focused biotechnology company.

Read More »

Immunomedics’ CEO and President Steps Down

Morris Plains, N.J.-based Immunomedics announced that the company’s president, chief executive officer and board member, Michael Pehl, was stepping down for personal reasons.

Read More »

Editas Medicine CEO Resigns, Sends Stocks Plunging

Shares of Editas Medicine were down nearly 20 percent after CEO Katrine Bosley abruptly announced her decision to resign from her role at the company effective March 1, 2019.

Read More »

Swiss drugmaker Roche’s diagnostics head exits

Roche diagnostics head Roland Diggelmann is resigning as of Sept. 30, ending a 10-year stint at the Swiss drugmaker.

Read More »

Celgene’s Chief Operating Officer Resigns

Scott Smith, Celgene’s chief operating officer, abruptly resigned as his decision to leave appears to be prompted by a restructuring of the company’s executive team.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!

Subscribe

Ad Right Bottom